France vs Vanuatu: Previously treated cases tested for RR-/MDR-TB
France
4.2%
in 2024
Vanuatu
0.0%
in 2024
France rank
170th
Vanuatu rank
173rd
Previously treated cases tested for RR-/MDR-TB over time
- France
- Vanuatu
How they compare
France currently reports 4.2% against 0.0% in Vanuatu, a difference of 4.2%.
The two have swapped places 2 times across 11 shared years of data; in 2009 it was France ahead.
France ranks 170th and Vanuatu ranks 173rd of 180 countries.
Across the 3 decades both report, France averaged higher in 2 and Vanuatu in 1.
Head to head by decade
| Decade | France | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.0% | 0.0% | 30.0% | France |
| 2010s | 90.0% | 8.3% | 81.7% | France |
| 2020s | 7.0% | 25.0% | 18.0% | Vanuatu |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, France or Vanuatu?
- France, at 4.2% against 0.0% in Vanuatu as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between France and Vanuatu?
- 4.2%, with France ahead.
- How many years of comparable data are there for France and Vanuatu?
- 11 years are reported by both, from 2009 to 2024.
- How do France and Vanuatu rank globally for previously treated cases tested for rr-/mdr-tb?
- France ranks 170th and Vanuatu ranks 173rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.